What You Should Know
Parexel has introduced ParexelAI™, a proprietary suite of human-led AI services designed to accelerate clinical development operations.Quantified Efficiencies: The suite is already delivering a 50% reduction in site selection timelines, a 30% reduction in medical writing for Clinical Study Reports, and a 20% reduction in safety literature screening.Regulatory Acceleration: Through a strategic partnership with Weave Bio, Parexel is reducing Investigational New Drug (IND)
Read More
Archives for 2026
M&A: Qualtrics Completes $6.75B Acquisition of Press Ganey Forsta
What You Should Know
Qualtrics has officially completed its acquisition of healthcare experience leader Press Ganey Forsta for $6.75B, marking the largest technology acquisition in Utah history.Category Expansion: The deal fuses Qualtrics’ experience management (XM) AI and data platform with Press Ganey Forsta's massive clinical, operational, and regulatory benchmarking footprint.The "Experience Gap" Mandate: Driven by consumer expectations permanently altered by AI, modern patients no longer
Read More
The Next AI Use Case in Radiology Isn’t Diagnosis. It’s Patient Understanding
For years, the debate around AI in radiology has been framed in the biggest possible terms. Will it replace radiologists? Will it outperform specialists? Will it make diagnostic imaging faster, cheaper, and more accurate?
Those questions matter. But they can distract from a more immediate and practical opportunity. The first truly scalable use of AI in imaging may not be autonomous diagnosis. It may be helping patients understand the imaging information they already receive.
That is a
Read More
Viz.ai Launches Viz Pulmonary™ Suite: AI-Powered Workflows for COPD, Lung Nodules, and PE
What You Should Know
Viz.ai has introduced the Viz Pulmonary™ Suite, an integrated AI solution designed to manage acute and chronic pulmonary conditions in a single platform.The suite targets three major pulmonary challenges: Chronic Obstructive Pulmonary Disease (COPD), lung nodules, and pulmonary embolism (PE).Clinical Impact: In a single-center study, the integrated Viz PE tool reduced time to treatment from 1.75 days to 0.56 days and lowered in-hospital mortality among high-risk
Read More
Healthcare AI Evaluation Frameworks: Moving Beyond Accuracy to Safety and Fairness
AI adoption is rapidly growing in healthcare across everything from clinical documentation to diagnostic imaging, revenue cycle management, and patient engagement. As per the 2023-24 American Hospital Association Information Technology Supplement, predictive AI integrated with EHR systems were already used in 71% of hospitals; this has increased rapidly with the advent of generative AI.
However, many AI deployments tend to fail in the real world, and do not deliver the expected improvements
Read More
FDA Grants 510(k) Clearance for Glooko’s EndoTool IV Cloud Insulin Dosing Platform
What You Should Know
Glooko has received U.S. FDA 510(k) clearance for EndoTool IV Cloud, making it the first cloud-based, patient-specific insulin dosing platform cleared for hospital use.The system is the cloud-native evolution of EndoTool IV, a clinical decision support solution used to manage intravenous (IV) insulin therapy for hospitalized patients.The cloud architecture is designed to reduce on-premise infrastructure requirements, streamline maintenance, and support centralized updates
Read More
KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses
What You Should Know
The number of hospitals impacted by EHR purchase decisions dropped 40% compared to 2024 and nearly 50% compared to 2023, according to a new KLAS 2026 EMR Market Share report.Shift to AI: Health systems redirected capital toward technologies with immediate financial returns, specifically AI and operational efficiency solutions, rather than core EHR upgrades.Epic Dominance: Epic was the only vendor selected by large health systems (>10 hospitals) in 2025 and added 77
Read More
Innovaccer 2026 Payer AI Report: Nearly 80% of Insurers to Buy or Co-Develop AI Capabilities
What You Should Know
Nearly 80% of health plan executives now plan to buy or co-develop AI capabilities with vendors, a sharp reversal from late 2024 when 78% were attempting to build internally, according to a new report from Innovaccer. Financial Commitment: Approximately 75% of payers intend to spend over $10 million on AI-driven payment and care outcome initiatives over the next 3–5 years.Operational Reality: Despite high ambitions, 86% of payers admit they are not fully ready to
Read More
Optura Raises $17.5M to Measure Healthcare AI ROI and Performance
What You Should Know
Optura, an enterprise healthcare platform, has announced a $17.5M Series A funding round led by Salesforce Ventures, bringing its total funding to over $25M.The platform introduces ROAI™ (Return on AI Investment), a discipline designed to help healthcare organizations objectively measure the business value and viability of AI initiatives.Despite the industry spending over $18B on AI this year, approximately 95% of enterprise GenAI pilots have failed to produce measurable
Read More
Signant Health Acquires Ametris to Combine Wearable Data and eCOA Technology
What You Should Know
Signant Health has acquired Ametris (formerly known as ActiGraph) to combine electronic clinical outcome assessment (eCOA) technology with wearable-based digital measurements. Financial details of the acquisition were not disclosed. The deal addresses a primary industry bottleneck by replacing multiple disconnected vendors with a single platform for both subjective patient feedback and objective sensor data.The integrated system is designed to support decentralized
Read More
